InvestorsHub Logo
Followers 120
Posts 20426
Boards Moderated 0
Alias Born 06/13/2011

Re: None

Monday, 05/13/2024 6:23:36 PM

Monday, May 13, 2024 6:23:36 PM

Post# of 232
From ER

“This is an exciting time for Unicycive as we progress towards the conclusion of our pivotal clinical trial for our lead asset oxylanthanum carbonate (OLC),” said Shalabh Gupta, M.D., Chief Executive Officer of Unicycive. “The trial is evaluating the tolerability, safety, and pharmacokinetics of clinically effective doses of OLC in patients with chronic kidney disease (CKD) on dialysis and it remains on track with topline data expected later this quarter.



Recent interview the Ceo said data in next few weeks.
Based on reported time line the trial should be completely finished by the end of this week ...May 18th
So data checking / cleaning 2-4 wks ??

Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent UNCY News